Developmental origin of polycystic ovary syndrome - A hypothesis

Journal of Endocrinology

Volumn 174, Issue 1, 2002, Pages 1-5

  Abbott, D H ^a   Dumesic, D A ^a   Franks, S ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; INSULIN; LUTEINIZING HORMONE;

ANDROGEN RELEASE; ANOVULATION; BIOCHEMISTRY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; FEMALE; GENE CONTROL; HEREDITY; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHESIS; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRENATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; PUBERTY; REVIEW; RHESUS MONKEY; RISK ASSESSMENT; SHEEP; STATISTICAL MODEL; SUBFERTILITY;

ANDROGENS; ANIMALS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LUTEINIZING HORMONE; MACACA MULATTA; OVARIAN DISEASES; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SHEEP;

EID: 0036313064     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1740001     Document Type: Review

References (39)

1. Insights into the development of PCOS from studies of prenatally androgenized female rhesus monkeys
2. Sex difference in the phosphorylation of cAMP response element binding protein (CREB) in neonatal rat brain
3. Role of the ovary in the adrenal androgen excess of hyperandrogenic women
4. Elevated concentrations of the beta-subunit of human chorionic gonadotropin and testosterone in the amniotic fluid of gestations of diabetic mothers
5. Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: Evidence for perinatal masculinization of neuroendocrine function in women
6. Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: Circulating levels of gonadotropins, their common alpha-subunit and free testosterone, and discrepancy between immunological and of circulating follicle-stimulating hormone
7. Human granulosa cells are the site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production
8. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing
9. Insulin resistance and the polycystic ovarian syndrome: Mechanism and implications for pathogenesis
10. Polycystic ovary syndrome: Evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone
11. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
12. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys
13. Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess
14. Polycystic ovary syndrome: A changing perspective
15. The ubiquitous polycystic ovary
16. The genetic basis of polycystic ovary syndrome
17. Association of the steroid synthesis gene GYP11a with polycystic ovary syndrome and hyperandrogenism
18. Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries
19. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome
20. Timing of prenatal androgen exposure: Anatomical and endocrine effects on juvenile male and female rhesus monkeys
21. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome
22. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: Role of insulin sensitivity and luteinizing hormone
23. Anovulation after precocious pubarche: Early markers and time course in adolescence
24. Phenotype and genotype in polycystic ovary syndrome
25. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
26. Gestational hyperandrogenism
27. Prenatal exposure to androgens leads to the development of cystic ovaries in the sheep
28. Androgen formation from pregnenolone sulfate by the human fetal ovary
29. In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone
30. Sexual differentiation and feedback control of luteinizing hormone secretion in the rhesus monkey
31. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome
32. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus
33. Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin
34. Searching for the polycystic ovary syndrome genes
35. Allelic variants of the follistatin gene in polycystic ovary syndrome
36. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome
37. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome
38. Differential activity of the cytochrome P450 17 alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells
39. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: Relevance to mechanism of anovulation